Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Current Pharmaceutical Design|December 7, 2010
HIV-1 (co)receptors: implications for vaccine and therapy designGeorgios Pollakis, William A PaxtonCurrent Opinion in HIV and AIDS|July 31, 2012
Use of (alternative) coreceptors for HIV entryGeorgios Pollakis, William A PaxtonCurrent Opinion in HIV and AIDS|August 10, 2011
Innate immune factors associated with HIV-1 transmissionGeorgios Pollakis, Martijn J Stax, William A PaxtonJournal of Virological Methods|April 5, 2014
The search for a T cell line for testing novel antiviral strategies against HIV-1 isolates of diverse receptor tropism and subtype originElena Herrera-Carrillo, William A Paxton, Ben BerkhoutFrontiers in Cellular and Infection Microbiology|April 23, 2020
Measuring the Success of HIV-1 Cure StrategiesJordan Thomas, Alessandra Ruggiero, William A Paxton, et al.Retrovirology|February 1, 2007
Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytesMarloes A Naarding, Elly Baan, Georgios Pollakis, et al.Current Opinion in HIV and AIDS|March 14, 2012
Effects of helminths and Mycobacterium tuberculosis infection on HIV-1: a cellular immunological perspectiveEmily E I M Mouser, Georgios Pollakis, William A PaxtonJournal of Virology|June 6, 2008
Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in transThijs van Montfort, Adri A M Thomas, Georgios Pollakis, et al.Journal of Virological Methods|October 17, 2018
Comparative analysis and generation of a robust HIV-1 DNA quantification assayJordan Thomas, Alessandra Ruggiero, Francesco A Procopio, et al.Plos One|May 24, 2007
Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1Alexey A Nabatov, Georgios Pollakis, Thomas Linnemann, et al.Pageof 7